Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
Claesson
K
K
Department of Transplantation Surgery, Uppsala University Hospital, Sweden.
Mayer
A D
AD
Squifflet
J P
JP
Grabensee
B
B
Eigler
F W
FW
Behrend
M
M
Vanrenterghem
Y
Y
van Hooff
J
J
Morales
J M
JM
Johnson
R W
RW
Buchholz
B
B
Land
W
W
Forsythe
J L
JL
Neumayer
H H
HH
Ericzon
B G
BG
Mühlbacher
F
F
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005060:Europe; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008074:Lipoproteins / Q000097:blood*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D008074:Lipoproteins; D016572:Cyclosporine; D002784:Cholesterol; D001379:Azathioprine; D016559:Tacrolimus